• Explore /
  • Poster
  • / A phase 2, open-label, multicenter study to evaluate the efficacy, safety, and tolerability of KN046 in combination with chemotherapy in subjects with advanced non-small cell lung cancer.

A phase 2, open-label, multicenter study to evaluate the efficacy, safety, and tolerability of KN046 in combination with chemotherapy in subjects with advanced non-small cell lung cancer.

Abstract Video & Slides Poster

Authors

null

Yunpeng Yang

Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China

Yunpeng Yang , Wenfeng Fang , Yan Huang , Xingya Li , Siyuan Huang , Jingxun Wu , Yibin Li , Baoping Chang , Sheng Hu , Shujun Yang , June Xu , Hardy Van , Lihua Zhi , Yue Xia , Fei Yang , Yi Xia , Paul Kong , Wei Dong , Ting Xu , Li Zhang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Lung Cancer—Non-Small Cell Metastatic

Track

Lung Cancer

Sub Track

Metastatic Non–Small Cell Lung Cancer

Clinical Trial Registration Number

NCT04054531

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 9060)

DOI

10.1200/JCO.2021.39.15_suppl.9060

Abstract #

9060

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Tony S. K. Mok

First Author: Panpan Zhang

First Author: Jiafu Ji

First Author: Jiwon Lee